Can Blizzard Keep Its Autonomy Post-Microsoft Acquisition? ‘No One Asking Us To Do Anything,’ Says World Of Warcraft Exec

Discover insights from Holly Longdale, World of Warcraft executive, on Blizzard's autonomy post-Microsoft acquisition.

Six months after Microsoft Corp.‘s (NASDAQ:MSFT) acquisition of Activision Blizzard, Holly Longdale, executive producer and vice president at World of Warcraft, provided insights into the post-acquisition environment.

In an interview with Video Games Chronicle, Longdale revealed Microsoft has largely allowed Blizzard to maintain its autonomy: “There’s no one asking us to do anything.”

See Also: China Welcomes Back World Of Warcraft As Blizzard, NetEase Reach Agreement

“World of Warcraft is doing very well and they’re very proud of what it’s been able to accomplish, so it’s almost like just let it be, and let it keep being awesome,” the executive added. “They’ve been tremendously supportive and it’s like ‘let Blizzard be Blizzard.’”

Longdale also highlighted the benefits of being part of the Microsoft family, mentioning opportunities for communication and information sharing with other Microsoft-owned studios. She mentioned interactions with teams from Mojang and Elder Scrolls Online, suggesting that they could learn from each other’s experiences.

Despite Longdale’s positive perspective, the acquisition has not been without its challenges.

Microsoft’s gaming division, including Activision Blizzard, underwent significant layoffs in January, affecting 1,900 employees and resulting in the cancellation of projects such as Odyssey.

In related news, Blizzard recently announced the upcoming expansion for World of Warcraft, titled “World of Warcraft: The War Within.” Although it may not match the impact of previous expansions, such as Dragonflight, anticipation remains high for its potential.

Read Next: Microsoft’s Satya Nadella: Activision Gives Us A Chance Of Being ‘A Good Publisher’ On Sony, Nintendo

Photo: CryptoFX on Shutterstock.

Total
0
Shares
Related Posts
Read More

Around $3M Bet On This Basic Materials Stock? Check Out These 4 Penny Stocks Insiders Are Buying

The Dow Jones closed higher by more than 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

AP

Read More

Cresco Labs And Temple University Join Forces To Research The Untapped Medical Benefits Of Cannabis

Temple University has been investigating the medical potential of cannabis for decades. Now, thanks to a new partnership with medical cannabis producer Cresco Labs (OTCQX: CRLBF), Temple is expanding its research into the ways cannabis can be used to treat conditions like chronic pain and food allergies.

CRLBF

Read More

Daré Bioscience Announces Publication In The Journal Of The North American Menopause Society Of Efficacy Findings For the Treatment Of Menopausal Symptoms From A Phase 1/2 Clinical Trial Of DARE-HRT1 Intravaginal Rings

DARE-HRT1 Demonstrated Preliminary Treatment Efficacy for Both Vasomotor Symptoms (VMS) and Genitourinary Syndrome of Menopause (GSM)The North American Menopause Society (NAMS) Guidance on Hormone Therapy States that

DARE